4-5 4-5 4-5

Examples of common applications include medical tubing, inflatables, packaging film and sheets, garden hoses, toys and automotive plastics. Selected for their strong performance and durability, phthalates are the most commonly used plasticizers in the world.1 In recent years, concerns have been raised over the use of phthalates, giving rise to myths and unfounded speculation. PHTHALATES FACTS PHTHALATES ARE KNOWN TO BREAK DOWN IN THE HUMAN BODY Research has shown that after entering the body, phthalate are broken down into metabolites within minutes and pass out quickly in urine.2 PHTHALATE EXPOSURE IS CONSIDERED LOW Despite the fact that phthalates are used in a wide range of products, human exposure from all sources is considered to be extremely low.2 PHTHALATES ARE A USEFUL CHOICE FOR HEALTHCARE Flexible vinyl tubing does not react with most medications, allowing for reliable administration of drugs, while flexible vinyl bags prevent blood contamination and extend shelf life of the blood.3 PHTHALATES ARE REGULATED Based on earlier studies, a few specific phthalates have been banned for use in toys or other items for sale to children under twelve to reduce risk of overexposure through hand-to- mouth behaviors. 1 Source: chemicalsafetyfacts.org 2 Source: Centers for Disease Control and Prevention 3 Source: thisisplastics.com www.avient.com Copyright © 2020, Avient Corporation.

Microsoft PowerPoint - AVNT Q4 2023 Earnings Presentation v7 AVIENT CORPORATION F O U R T H Q U A R T E R 2 0 2 3 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) F E B R U A RY 1 4 , 2 0 2 4 DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. A reconciliation of these measures to their most directly comparable GAAP measures is provided in the tables below. 2023 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income (loss) from continuing operations attributable to Avient shareholders $ 27.8 $ 0.30 $ (17.0) $ (0.19) Special items, after tax (Attachment 3) 5.4 0.06 38.3 0.42 Amortization expense, after-tax 15.0 0.16 14.6 0.16 Adjusted net income / EPS $ 48.2 $ 0.52 $ 35.9 $ 0.39 (1) Per share amounts may not recalculate from figures presented herein due to rounding 2023 2022 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 75.8 $ 0.83 $ 82.8 $ 0.90 Special items, after tax (Attachment 3) 79.3 0.86 116.2 1.26 Amortization expense, after-tax 61.5 0.67 49.0 0.53 Adjusted net income / EPS $ 216.6 $ 2.36 $ 248.0 $ 2.69 (1) Per share amounts may not recalculate from figures presented herein due to rounding 1 Reconciliation to EBITDA and Pro Forma Adjusted EBITDA 2023 2022 2023 2022 Sales - GAAP $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Pro forma APM adjustments — — — 256.1 Pro forma adjusted sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,653.0 Net income (loss) from continuing operations – GAAP $ 27.6 $ (16.6) $ 76.3 $ 83.1 Income tax (benefit) expense (7.0) (60.8) 11.0 (19.3) Interest expense 26.8 49.4 115.3 119.8 Depreciation and amortization from continuing operations 44.2 48.6 188.8 162.5 EBITDA from continuing operations $ 91.6 $ 20.6 $ 391.4 $ 346.1 Special items, before tax 22.4 104.3 114.6 194.0 Interest expense included in special items (0.1) (16.0) (2.3) (26.0) Depreciation and amortization included in special items — (1.5) (1.9) (5.5) Adjusted EBITDA $ 113.9 $ 107.4 $ 501.8 $ 508.6 APM pro forma adjustments - 8 months 2022* — — — 83.1 Pro forma adjusted EBITDA $ 113.9 $ 107.4 $ 501.8 $ 591.7 Pro forma adjusted EBITDA as a percent of sales 15.8 % 13.6 % 16.0 % 16.2 % * Pro forma adjustment for January - August 2022 APM results (period before Avient ownership).

Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. Expand EBITDA margins to 20% 3. Deliver annual EBITDA and EPS growth of 10% and 15% 4.

Microsoft PowerPoint - AVNT Fermium Conference - May 2023 AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) M AY 4 , 2 0 2 3 H O S T E D B Y : DISCLAIMER Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022. F X ) -10% -11% -3% -12% 14 Avient ex.

TP BLACK UV 4 FABULOUS FUSHIA 4 GREY HIPS 3

SILVER ABS 716-2-3 GLOW GREEN 4% RHODASURF L-4

X GV SR-15328-1 White Swirl X GV SR-15362-1 Copper x GV SR-15361-4 Black

1. 3. 4.

POLYSTRAND™ THERMOPLASTIC PANELS MATERIALS AND CHARACTERISTICS Facesheet Resins Polypropylene (PP) PETG Facesheet Reinforcement Glass Fiber Core Materials PET Foam PP Honeycomb Characteristics Lightweight Excellent Impact Resistance Formable Value Engineered Facesheets Recyclable 2-layer Composite Laminate Unidirectional Composite Tape 3-layer Composite Laminate 0°/90°/0° 4-layer Composite Laminate 0°/90°/90°/0° POLYSTRAND™ CONTINUOUS FIBER LAMINATES Configuration Wood & Polystrand X-ply Aluminum & Polystrand X-ply Common Material Reinforcements POLYSTRAND™ COMPOSITE SANDWICH PANELS Configuration Fiber Reinforced Facesheet Fiber Reinforced Facesheet Core Material